VAERS Explorer
Back to explore

Report #2900150

Received Jun 15, 2026

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Female
Age
Age unknown
State
Recovered
Not recovered
Vaccinated
Feb 1, 2019
Onset
Days to onset
Hospital days

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
VARZOSZOSTER (SHINGRIX)GLAXOSMITHKLINE BIOLOGICALS2

Symptoms (1)

Dyspnoea

Symptom narrative

she was recently in the hospital and is feeling short of breath/winded today; This non-serious case was reported by a consumer via call center representative and described the occurrence of shortness of breath in a female patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (received first dose on an unknown date in 2018). In FEB-2019, the patient received the 2nd dose of Shingrix. On an unknown date, more than 2 years after receiving Shingrix, the patient experienced shortness of breath (Verbatim: she was recently in the hospital and is feeling short of breath/winded today). The outcome of the shortness of breath was not resolved. It was unknown if the reporter considered the shortness of breath to be related to Shingrix. Additional Information: GSK Receipt date: 08-JUN-2026 The patient stated that had received shot 1 of Shingrix in late 2018 and shot 2 of Shingrix in FEB-2019. The patient had gone to the pharmacy recently, where patient had been told that needed to have her shingles shot updated, but patient had declined a third dose. The patient stated that had recently been in the hospital and had felt short of breath/winded on that day. The batch number had not been provided upon follow-up with the reporter.